Author:
Ilżecka J.,Stelmasiak Z.,Solski J.,Wawrzycki S.,Szpetnar M.
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Clinical Biochemistry,Biochemistry
Reference28 articles.
1. Babu GN, Bawari M, Mathur VN, Kalita J, Misra UK (1998) Blood glutamate levels in patients with motor neuron disease. Clin Chim Acta 273: 195–200
2. Bendotti C, Tortarolo M, Suchak SK, Calvaresi N, Carvelli L, Bastone A, Rizzi M, Rattray M, Mennini T (2001) Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. J Neurochem 79: 737–746
3. Blin O, Desnuelle C, Guelton C, Aubrespy G, Ardissone JP, Crevat A, Pouget J, Serratrice G (1991) Anomaly in the neurotransmitter amino acids in amyotrophic lateral sclerosis: a therapeutic application. Rev Neurol (Paris) 147: 392–394
4. Brooks BR (1994) El Escorial Word Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 124 [Suppl]: 96–107
5. Camu W, Billiard M, Baldy–Moulinier M (1993) Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis. Acta Neurol Scand 88: 51–55